These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intracellular localization of dysferlin and its association with the dihydropyridine receptor. Ampong BN; Imamura M; Matsumiya T; Yoshida M; Takeda S Acta Myol; 2005 Oct; 24(2):134-44. PubMed ID: 16550931 [TBL] [Abstract][Full Text] [Related]
4. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle. Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176 [TBL] [Abstract][Full Text] [Related]
5. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985 [TBL] [Abstract][Full Text] [Related]
6. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition. Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532 [TBL] [Abstract][Full Text] [Related]
7. Caveolin regulates endocytosis of the muscle repair protein, dysferlin. Hernández-Deviez DJ; Howes MT; Laval SH; Bushby K; Hancock JF; Parton RG J Biol Chem; 2008 Mar; 283(10):6476-88. PubMed ID: 18096699 [TBL] [Abstract][Full Text] [Related]
8. Cells Control BIN1-Mediated Membrane Tubulation by Altering the Membrane Charge. Gowrisankaran S; Wang Z; Morgan DG; Milosevic I; Mim C J Mol Biol; 2020 Feb; 432(4):1235-1250. PubMed ID: 31857086 [TBL] [Abstract][Full Text] [Related]
9. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630 [TBL] [Abstract][Full Text] [Related]
10. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595 [TBL] [Abstract][Full Text] [Related]
11. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies. Cárdenas AM; González-Jamett AM; Cea LA; Bevilacqua JA; Caviedes P Exp Neurol; 2016 Sep; 283(Pt A):246-54. PubMed ID: 27349407 [TBL] [Abstract][Full Text] [Related]
12. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect. Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro dysferlin expression in human muscle satellite cells. De Luna N; Gallardo E; Illa I J Neuropathol Exp Neurol; 2004 Oct; 63(10):1104-13. PubMed ID: 15535137 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic dysferlin gene mutation carriers: characterization of two cases. Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450 [TBL] [Abstract][Full Text] [Related]